- ►angrylapdog.com JM Lawrence, R Contreras, W Chen, DA … - Diabetes Care, 2008 - care.diabetesjournals.org.p.angrylapdog.com RESULTS—Preexisting diabetes was identified in 2,784 (1.3%) of all
pregnancies, rising from an age- and race/ethnicity-adjusted prevalence of 0.81
per 100 in 1999 to 1.82 per 100 in 2005 (P trend < 0.001). Significant ... Cited by 19 - Related articles - All 4 versions
S Seshadri, PA Wolf - Lancet Neurology, 2007 - Elsevier The main neurological causes of morbidity and mortality are stroke and dementia.
We contend that the most relevant and readily communicated risk estimate for
stroke and dementia is lifetime risk, which is the probability of someone ... Cited by 17 - Related articles - All 13 versions
- ►nih.gov - Free from Publisher CS Fox, MJ Pencina, PWF Wilson, NP Paynter, … - Diabetes care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Participants were drawn from the original and
offspring cohorts of the Framingham Heart Study. Lifetime (30-year) risk of CVD
was assessed using a modified Kaplan-Meier approach adjusting for the ... Cited by 9 - Related articles - All 6 versions
DJ Magliano, JE Shaw, SM Shortreed, WJ … - Diabetologia, 2008 - Springer Abstract Aims/hypothesis With incidence rates for diabetes increas- ing rapidly
worldwide, estimates of the magnitude of the impact on population health are
required. We aimed to estimate the lifetime risk of diabetes, the number of ... Cited by 5 - Related articles - All 2 versions
- ►umich.edu [PDF] SC Maty, JW Lynch, TE Raghunathan, GA … - American Journal of Public Health, 2008 - Am Public Health Assoc Siobhan C. Maty is with the School of Community Health, Portland State
University, Portland, OR. John W. Lynch is with the Department of Epidemiology,
Biostatistics, and Occupational Health, McGill University, Montreal, ... Cited by 5 - Related articles - All 6 versions
CV Rizos, M Elisaf, DP Mikhailidis, EN … - Expert Opin. Drug Saf., 2009 - informahealthcare.com Background: Thiazolidinediones (TZDs) are widely used antidiabetic drugs with
proven efficacy regarding mainly surrogate markers of diabetes management.
However, efficacy on surrogate markers may not always translate into ... Cited by 5 - Related articles - All 5 versions
- ►dvdres.co.uk [PDF] J Saltevo, M Vanhala, H Kautiainen, M … - Diabetes and Vascular Disease Research, 2007 - dvdres.co.uk Abstract Obesity has been related to subclinical inflamma- tion and decreased
levels of adiponectin. We examined the relationship between inflammatory markers
and adiponectin and the change in body mass index (BMI) between childhood ... Cited by 3 - Related articles - BL Direct - All 7 versions
PN Surampudi, J John-Kalarickal, VA … - Mt Sinai J Med, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 2 - Related articles - All 2 versions
K Coppell, S Williams, K Anderson, C Lamb, … - Diabetes Research and Clinical Practice, 2008 - Elsevier We compared clinical and metabolic characteristics and estimated cardiovascular
risk for 2073 new cases of type 2 diabetes enrolled on the Otago Diabetes
Register, 1998–2004 by age at diagnosis (<40 years, 40–59 years, ... Cited by 2 - Related articles - All 22 versions
R Gupta, VP Gupta, N Bhagat, P Rastogi, M … - Indian heart journal - ncbi.nlm.nih.gov OBJECTIVE: The impact of rising population-wide obesity on cardiovascular risk
factors has not been well studied in low-income countries. To correlate the
prevalence of obesity with risk factors we performed epidemiological ... Cited by 1 - Related articles - BL Direct - All 5 versions
